81 related articles for article (PubMed ID: 19799080)
41. [Regulation of differentiation and proliferation of epiphysis stem cells by Notch1 signaling system].
Zhang YB; Chen AM; Guo FJ; Huang SL; Xiong WH; Li Q
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3430-4. PubMed ID: 16409866
[TBL] [Abstract][Full Text] [Related]
42. [Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells].
Liu YZ; Li JJ; Zhang FR; Shen Y; Yao M; Wan DF; Gu JR
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jun; 35(6):548-53. PubMed ID: 12796816
[TBL] [Abstract][Full Text] [Related]
43. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y; Bai Y; Zhang F; Wang Y; Guo Y; Guo L
Biochem Biophys Res Commun; 2010 Jan; 391(3):1483-9. PubMed ID: 20034472
[TBL] [Abstract][Full Text] [Related]
44. Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy.
Ejma M; Misiuk-Hojło M; Gorczyca WA; Podemski R; Szymaniec S; Kuropatwa M; Rogozińska-Szczepka J; Bartnik W
Breast Cancer Res Treat; 2008 Jul; 110(2):269-71. PubMed ID: 17851760
[TBL] [Abstract][Full Text] [Related]
45. Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells.
Stovold R; Blackhall F; Meredith S; Hou J; Dive C; White A
Lung Cancer; 2012 Jun; 76(3):263-8. PubMed ID: 22177533
[TBL] [Abstract][Full Text] [Related]
46. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
47. [Diagnostic value of microtubule-associated protein-2 in small cell lung carcinoma: an analysis of 240 biopsy cases].
Zhou DM; Sun Y; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):321-4. PubMed ID: 24004589
[TBL] [Abstract][Full Text] [Related]
48. Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer.
Hong D; Knelson EH; Li Y; Durmaz YT; Gao W; Walton E; Vajdi A; Thai T; Sticco-Ivins M; Sabet AH; Jones KL; Schinzel AC; Bronson RT; Nguyen QD; Tolstorukov MY; Vivero M; Signoretti S; Barbie DA; Oser MG
Cancer Res; 2022 Jan; 82(2):248-263. PubMed ID: 34810201
[TBL] [Abstract][Full Text] [Related]
49. Pro-Gastrin-Releasing Peptide as a Marker of Small Cell Lung Cancer.
Lyubimova NV; Kuz'minov AE; Markovich AA; Lebedeva AV; Timofeev YS; Stilidi IS; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):257-260. PubMed ID: 35737164
[TBL] [Abstract][Full Text] [Related]
50. Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.
Hassan WA; Takebayashi SI; Abdalla MOA; Fujino K; Kudoh S; Motooka Y; Sato Y; Naito Y; Higaki K; Wakimoto J; Okada S; Nakao M; Ishikawa Y; Ito T
Lab Invest; 2017 Aug; 97(8):913-921. PubMed ID: 28414324
[TBL] [Abstract][Full Text] [Related]
51. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.
Lim JS; Ibaseta A; Fischer MM; Cancilla B; O'Young G; Cristea S; Luca VC; Yang D; Jahchan NS; Hamard C; Antoine M; Wislez M; Kong C; Cain J; Liu YW; Kapoun AM; Garcia KC; Hoey T; Murriel CL; Sage J
Nature; 2017 May; 545(7654):360-364. PubMed ID: 28489825
[TBL] [Abstract][Full Text] [Related]
52. Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives.
Guo L; Zhang T; Xiong Y; Yang Y
Dis Markers; 2015; 2015():520590. PubMed ID: 26491213
[TBL] [Abstract][Full Text] [Related]
53. Neuroendocrine characteristics in malignant lung tumors: implications for diagnosis, treatment, and prognosis.
Senderovitz T; Skov BG; Hirsch FR
Cancer Treat Res; 1995; 72():143-54. PubMed ID: 7702985
[No Abstract] [Full Text] [Related]
54. Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma.
Zhang X; Yu Z
J Healthc Eng; 2022; 2022():2311471. PubMed ID: 35646297
[TBL] [Abstract][Full Text] [Related]
55. Second-generation Notch1 activity-trap mouse line (N1IP::CreHI) provides a more comprehensive map of cells experiencing Notch1 activity.
Liu Z; Brunskill E; Boyle S; Chen S; Turkoz M; Guo Y; Grant R; Kopan R
Development; 2015 Mar; 142(6):1193-202. PubMed ID: 25725069
[TBL] [Abstract][Full Text] [Related]
56. [Calcium-binding protein secretagogin is a novel neuroendocrine marker].
Wang WJ; Zhang F; Xu GX; Chen C
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):627-8. PubMed ID: 21092592
[No Abstract] [Full Text] [Related]
57. Immunohistochemistry for small-cell carcinoma: a potential diagnostic pitfall.
Wallace WA; Dorward DA; Salter DM
Histopathology; 2019 Apr; 74(5):792-794. PubMed ID: 30431185
[No Abstract] [Full Text] [Related]
58. Small cell, big problem! Stem cells, root cause?
Subramanian J; Govindan R
Clin Lung Cancer; 2008 Sep; 9(5):252-3. PubMed ID: 18824446
[No Abstract] [Full Text] [Related]
59. A Multiplexed Approach to Assess Small Cell Lung Cancer Subtype Heterogeneity in Primary and Patient-Derived Tumor Samples.
Ng J; Pan E; Johnston A; Ribera NT; Kersbergen A; Hess JB; Best SA; Tsui E; Steinfort D; Sutherland KD
Methods Mol Biol; 2024; 2806():117-138. PubMed ID: 38676800
[TBL] [Abstract][Full Text] [Related]
60. Refined cancer stem cells-enriched lung cancer model systems: Cross-talk and fine-tuning Notch1 inhibition.
Suresh PK
J Cancer Res Ther; 2022; 18(3):866-867. PubMed ID: 35900580
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
